This company has been marked as potentially delisted and may not be actively trading. AVROBIO (AVRO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AVRO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cystinosis Treatment Market Set for Robust Growth Through 2034, Driven by Recent Developments in Clinical Pipeline | DelveInsightJune 13, 2025 | theglobeandmail.comTECX Stock Hits 52-Week High, Soaring to $53.6 Amid Market OptimismJanuary 30, 2025 | msn.comOptimistic Outlook for Tectonic Therapeutic’s TX45: A Promising Candidate for Unmet Medical NeedsJanuary 28, 2025 | markets.businessinsider.comL'action TECX atteint un sommet sur 52 semaines à 53,41$December 25, 2024 | fr.investing.comL'action TECX atteint un sommet sur 52 semaines à 47,99$ dans un contexte de hausse des marchésNovember 13, 2024 | fr.investing.comPromising Potential and Strong Safety Profile Drive Buy Rating for Tectonic TherapeuticNovember 13, 2024 | markets.businessinsider.comTectonic Therapeutic: Promising Phase 1a Results and Strong Financial Health Justify Buy RatingNovember 11, 2024 | markets.businessinsider.comL'action TECX atteint un plus haut de 52 semaines à 38,14$ dans un contexte d'optimisme du marchéOctober 25, 2024 | fr.investing.comLe titre TECX atteint un plus haut de 52 semaines à 34,54$ dans un contexte de rallye boursierOctober 15, 2024 | fr.investing.comTD Cowen Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)September 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for Tectonic Therapeutics Following Promising TX45 Trial Results and Future CatalystsSeptember 21, 2024 | markets.businessinsider.comL'action TECX atteint un sommet de 52 semaines à 19,68$ dans un contexte d'optimisme du marchéSeptember 19, 2024 | fr.investing.comBuy Rating Affirmed on Tectonic Therapeutics’ TX45 for Promising Clinical AdvancementsAugust 15, 2024 | markets.businessinsider.comTectonic Therapeutic: Analyzing Its Post-Merger Valuation And ProspectsAugust 4, 2024 | seekingalpha.comTectonic Therapeutic Inc (TECX)August 2, 2024 | investing.comJuly M&A deals: Eli Lilly, Desktop Metal and Eastern Bank.August 1, 2024 | bizjournals.comGlobal Gene Therapy Strategic Research Report 2024-2030: Availability of Novel Therapies Drive Market GrowthJuly 31, 2024 | uk.finance.yahoo.comTectonic Therapeutic Inc TECXJuly 31, 2024 | morningstar.comMTectonic Therapeutic Announces US IND Clearance for Lead Program, TX45July 31, 2024 | tmcnet.comWhy Is Avrobio (AVRO) Stock Moving Today?June 20, 2024 | investorplace.comAVROBIO Stock Scheduled to Reverse Split on Thursday, June 20th (NASDAQ:AVRO)June 18, 2024 | marketbeat.comAVROBIO, Inc. (NASDAQ:AVRO) Short Interest UpdateJune 14, 2024 | marketbeat.comTectonic Therapeutic Appoints Daniel Lochner as Chief Financial OfficerJune 3, 2024 | businesswire.comShort Interest in AVROBIO, Inc. (NASDAQ:AVRO) Increases By 11.3%June 1, 2024 | marketbeat.comBraden Michael Leonard Buys 469,753 Shares of AVROBIO, Inc. (NASDAQ:AVRO) StockMay 16, 2024 | insidertrades.comAVROBIO, Inc. (AVRO) Stock Price, News, Quote & History - Yahoo FinanceMay 16, 2024 | finance.yahoo.comUn cadre d'Avrobio achète des actions d'une valeur de plus de 970 000 dollarsMay 15, 2024 | fr.investing.comInsider Buying: AVROBIO, Inc. (NASDAQ:AVRO) Major Shareholder Acquires 469,753 Shares of StockMay 15, 2024 | marketbeat.comShort Interest in AVROBIO, Inc. (NASDAQ:AVRO) Expands By 19.0%May 14, 2024 | marketbeat.comAVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVROMay 9, 2024 | businesswire.comDeal watch: Biopharma M&A more than doubled in Q1April 22, 2024 | bizjournals.comShort Interest in AVROBIO, Inc. (NASDAQ:AVRO) Rises By 14.6%April 14, 2024 | marketbeat.comAVROBIO Inc.March 26, 2024 | wsj.comAVROBIO (AVRO) Scheduled to Post Quarterly Earnings on ThursdayMarch 20, 2024 | marketbeat.comAVROBIO, Inc. (NASDAQ:AVRO) Short Interest Down 30.3% in FebruaryMarch 1, 2024 | marketbeat.comAVRO Apr 2024 2.500 callFebruary 23, 2024 | ca.finance.yahoo.comAVRO May 2024 2.500 callFebruary 18, 2024 | finance.yahoo.comAVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVROFebruary 14, 2024 | businesswire.comShareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with TectonicJanuary 31, 2024 | stockhouse.comFive things: Vertex's new drug, a reverse merger, and how are you doing?January 31, 2024 | bizjournals.comAvrobio Inc Announces Executive Team Changes and AppointmentsJanuary 31, 2024 | msn.comAvrobio to take Watertown biotech public via reverse mergerJanuary 30, 2024 | bizjournals.comSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AVRO, CALB, BCALJanuary 30, 2024 | stockhouse.comAvrobio to buy 100% equity interests of Tectonic TherapeuticJanuary 30, 2024 | msn.comAvrobio Shares Dive 17% After Tectonic Therapeutic DealJanuary 30, 2024 | marketwatch.comAVROBIO and Tectonic Therapeutic Announce MergerJanuary 30, 2024 | finance.yahoo.comAVROBIO (Nasdaq:AVRO) HeadlineTrading was temporarily halted for "AVRO" at 07:01 AM with a stated reason of "News pending."...January 30, 2024 | marketbeat.comAvrobio Stock (NASDAQ:AVRO), Analyst Ratings, Price Targets, PredictionsDecember 19, 2023 | benzinga.comMizuho Downgrades AVROBIO (AVRO)December 19, 2023 | msn.comAvrobio Stock (NASDAQ:AVRO) Dividends: History, Yield and DatesDecember 19, 2023 | benzinga.com Get AVROBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for AVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address AVRO Media Mentions By Week AVRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVRO News Sentiment▼0.001.01▲Average Medical News Sentiment AVRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVRO Articles This Week▼00▲AVRO Articles Average Week Get AVROBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for AVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inhibikase Therapeutics News Today Protalix BioTherapeutics News Today Invizyne Technologies News Today Achilles Therapeutics News Today ZIVO Bioscience News Today bluebird bio News Today Cyclo Therapeutics News Today NKGen Biotech News Today AlloVir News Today Calidi Biotherapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVRO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVROBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
